Bashing a stock that has quadrupled in a year and lost 60% since going public......then again, all pumpers conveniently pick the lowest price point before the dead cat bounce. Catalyst will miss their enrollment deadline again and they will dilute shareholders again.....bet on it.
Cant wait to see the egg on your face......Catalyst could screw up an order to toast......half the company should be in a retirement home and the other half should be selling used cars. This company will NEVER have a marketable product nor will they ever turn a profit.....I know it, you know it and Wall St (ie the non pay-for-play analysts) knows it.
Ahhhhh.....good old Dr Selvaraju.....he changes his price target weekly. If he knows so much, how come he didnt anticipate the first time Catalyst missed enrollment? 21 days and counting.....tick tock.
All that is missing is the press release.......I bet Catalyst will release a fluff PR to pump the stock price, follow up with a secondary, then drop the enrollment bomb before month's end. If youve followed Catalyst for more than a week, you should realize that Catalyst is a pure-play fund raising machine, much like many biotech shell companies. Catalyst sells a dream which is always just out of reach.....with a little more SG&A funding, that dream becomes ever closer. Riiiiiiight.
Lets make a bet then......if Catalyst doesnt punt on enrollment completion or raise funds by issuing shares before April 1st, I'll shut up......if they DO punt on enrollment or issue shares, then you admit that Catalyst is a bad investment.
You must be getting nervous if you are focusing on a poster's background versus the continual non-results of your investment. I believe they call this phenomenon "denial" in the world of psychology.
The same tired Powerpoint presentation with the same tired milestones with the same tired "adjustments" when those milestones get missed. Catalyst is trading downward because the market knows that either a) a postponement on firdapse enrollment will occur for a second time or b) the company will further dilute shareholders by issuing more shelf shares for the hundredth time. Either way, this turd is heading lower while Pat and the gang issue themselves more free stock through the new Incentive Compensation Plan. What a racket!!!!
Nope, I've been talking this dog down since it was @ $6/share many moons ago. Paid basher, blah blah blah.....and down goes the share price some more.
No doubt these guy will drop the inevitable bomb on a Friday post-close.....the market is obviously telling us something......either a dilutive offering or pushing the enrollment deadline for the "multi-site global clinical trial". It is amazing that this dog is still trading above $2/share.....a testimony to cheap money sloshing around and keeping #$%$ companies afloat.
Take your pick.....either a dilutive offering and/or a miss of the second enrollment deadline. More bumbling from the senior citizens down in Florida
Why buy now when you can purchase this stock for 50% less.....Catalyst will invariably raise funds through dilutive financing AND/OR whiff on their second enrollment deadline.
What will happen first, another capital raise or missing the firdapse enrollment deadline for a second time? If you cant enroll 36 patients in a trial, how will you sell firdapse to thousands?
More forward looking magic from Florida.....when do they move the enrollment deadline goalposts again? Will it be before or after Pat and the gang issue more shares from the shelf offering? Keep believing suckers....Pat's W2 depends on naive investors thinking they've found an undiscovered gem.
Or you can watch Whiting executives load up on production sharing agreements......if SM Energy bombed, you can bet that Whiting isnt far behind, especially with differentials exploding.
Because Catalyst makes it so darn easy to bash!!! How do you keep an idiot in suspense? I'll get back to you soon, just like Catalyst will with clinical results! LOL!
With $100 oil, Whiting's stock performance is a testament to management's incompetance. Aside from the millions in base/bonus and the sweetheart royalty agreements, why is this company still independent if future propects are so great?
Absolutely comical.....now the Tourette's results timeline is listed as "2014".....how on earth does a company list the milestone date for top line clinical trials results as a full year???? What idiot is running the clinical trial? Again, this company is a scam.....big talk about future results with little delivery or tangible results.
Almost all of the firms attending the BIO conference are doing webcasts......guess which company isnt webcasting their presentation? You guessed it.....Catalyst Pharmaceutical. This company is pure illusion....the only question is when will Pat and the gang dilute shareholders?
How about neither.....I bet Catalyst still wont have the Firdapse enrollment done by the end of Q1. That miss will be followed up by a prompt moving of the goalposts......rinse, wash, repeat